Methylprednisolone Attenuates Airway and Vascular Responses Induced by Reactive Oxygen Species in Isolated, Plasma-Perfused Rat Lungs

References

• Demling R. Role of oxygen radicals in acute lung injury. Adult Respiratory Distress Syndrome., A. Artigas, F. Lemaire, P. M. Suter, W. M. Zapol. Churchill Livingstone, Edinburgh-London-New York 1992; 121–140
   Google Scholar
• Ryrfeldt A., Bannenberg G., Moldéus P. Free radicals and lung disease. British Medical Bulletin 1993; 49: 589–603
   Web of Science ®Google Scholar
• Adult Respiratory Distress Syndrome, A. Artigas, F. Lemaire, P. M. Suter, W. M. Zapol. Churchill Livingstone, Edinburgh-London-New York 1992
   Google Scholar
• Sibbald W. J., Anderson R. R., Reid B., Holliday R. L. Alveolocapillary permeability in human septic ARDS. Effect of high-dose corticosteroid therapy. Chest 1981; 79: 133–142
   PubMed Web of Science ®Google Scholar
• Bernard G. R., Luce J. M., Sprung C. L., Rinaldo J. E., Tate R. M., Sibbald W. J., Kariman K., Higgins S., Bradley R., Metz C. A., Harris T. R., Brigham K. L. High-dose corticosteroids in patients with the adult respiratory distress syndrome. New England Journal of Medicine 1987; 317: 1565–1570
   PubMed Web of Science ®Google Scholar
• Svennevig J. L., Bugge-Asperheim B., Vaage J., Geiran O., Birkeland S. Corticosteroids in the treatment of blunt injury of the chest. Injury 1984; 16: 80–84
   PubMed Web of Science ®Google Scholar
• Tate R. M., Van Benthuysen K. M., Shasby D. M., McMurtry I. F., Repine J. E. Oxygen radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. American Review of Respiratory Disease 1982; 126: 802–806
   PubMed Web of Science ®Google Scholar
• Burghuber O. C., Strife R. J., Zirrolli J., Henson P. M., Henson J. E., Mathias M. M., Reeves J. T., Myrphy R. C., Voelkel N. F. Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide. American Review of Respiratory Disease 1985; 131: 778–785
   PubMed Web of Science ®Google Scholar
• Kjæve J., Vaage J., Bjertnæs L. Reactive oxygen intermediates reduce inactivation of serotonin in isolated, perfused rat lungs. Circulatory Shock 1989; 28: 79–87
   PubMedGoogle Scholar
• Kjæve J., Vaage J., Bjertnæs L. Increased microvascular permeability caused by toxic oxygen metabolites is partly reversed by exhanging the perfusate in isolated rat lungs. Acta Anaesthesiologica Scandinavica 1989; 33: 605–609
   PubMed Web of Science ®Google Scholar
• Kjæve J., Vaage J., Bjertnæs L. Toxic oxygen metabolites reduce inactivation of PG2 in isolated, perfused rat lungs. International Journal of Microcirculation.: Clinical and Experimental 1992; 11: 85–93
   PubMedGoogle Scholar
• Kjæve J., Vaage J., Bjertnæs L. Toxic oxygen metabolites induce vasoconstriction and bronchoconstriction in isolated, plasma-perfused rat lungs. Acta Anaesthesiologica Scandinavica 1991; 35: 65–70
   PubMed Web of Science ®Google Scholar
• Olafsdottir K., Åyrfeldt R., Atzori L., Berggren M., Moldeus P. Hydroperoxide-induced broncho- and vasoconstriction in the isolated rat lung. Experimental Lung Research 1991; 17: 615–627
   PubMed Web of Science ®Google Scholar
• Olafsdottir K., Atzori L., Åyrfeldt R., Berggren M., Kumlin M., Moldeus P. Mechanisms of hydroperoxide-induced broncho- and vasoconstriction in isolated and perfused rat lung. Pharmacology and Toxicology 1991; 68: 191–186
   Google Scholar
• Blackwell G. J., Flower R. J., Nijkamp F. P., Vane J. R. Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation and inhibition by antiinflammatory steroids. British Journal of Pharmacology 1978; 62: 79–89
   PubMed Web of Science ®Google Scholar
• Hall E. D. The neuroprotective pharmacology of methylprednisolone. Journal of Neurosurgery 1992; 76: 13–22
   PubMed Web of Science ®Google Scholar
• Anderson D. K., Dugan L. L., Means E. D., Horrocks L. A. Methylprednisolone and membrane properties of primary cultures of mouse spinal cord. Brain Research 1994; 637: 119–125
   PubMed Web of Science ®Google Scholar
• Kjæve J., Naess L., Ingebrigtsen T., Vaage J., Bjertnæs L. Toxic oxygen metabolites increase microvascular permeability in isolated perfused rat lungs: The effect of methylprednisolone. Circulatory Shock 1991; 33: 228–232
   PubMedGoogle Scholar
• Ytrehus K., Myklebust R., Mjøs O. D. Influence of oxygen radicals generated by xanthine oxidase in the isolated perfused rat heart. Cardiovascular Research 1986; 20: 597–603
   PubMed Web of Science ®Google Scholar
• Valen G., Semb A. G., Vaage J. Inhibition of lipooxygenase and cyclooxygenase augments cardiac injury by H2O2. Free Radical Biology & Medicine 1993; 15: 27–35
   PubMed Web of Science ®Google Scholar
• Kjæve J. Lungs and toxic oxygen metabolites. An experimental study. Thesis, University of Tromsø, TromsøNorway 1991; 24
   Google Scholar
• Hauge A., Bö G., Aarseth P. Hydrostatic pulmonary edema in the cat. Effects on pulmonary blood and water volumes and on lung compliance. Acta Anaesthesiologica Scandinavica 1977; 21: 413–422
   PubMed Web of Science ®Google Scholar
• Goldstein I. M., Roos D., Weissman G., Kaplan H. B. Influence of corticosteroids on human polymorphonuclear leukocyte function in vitro. Inflammation 1976; 1: 305–315
   PubMedGoogle Scholar
• Stromme-Hansen L., Bjertnæs L., Vaage J. Methylprednisolone reduces vascular resistance in hypoxic and atelectatic lungs. Acta Anaesthesiologica Scandinavica 1985; 29: 446–452
   PubMed Web of Science ®Google Scholar
• Braude A. C., Rebuck A. S. Prednisone and methylprednisolone disposition in the lung. Lancet 1983; 2: 995–997
   PubMedGoogle Scholar
• Wilson J. W. Cellular localization of 3H-labelled corticosteroid by electron microscopic autoradiography after hemorragic shock. Steroids and Shock, T. M. Glenn. University park Press, Baltimore 1974; 275–289
   Google Scholar
• Lefer A. M. Corticosteroid and circulatory function. Handbook of Physiology, Endocrinology VI. The American Physiological Society. 1976; 191–207
   Google Scholar
• Vaage J. Effects of high-dose corticosteroids on the pulmonary circulation. Acta Chirurgica Scandinavica 1985; 73–82, Suppl. 526
   PubMedGoogle Scholar
• Hall E. D., Braughler J. M. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Journal of Neurosurgery 1982; 18: 320–327
   Google Scholar
• Kawamura T., Yoshioka T., Bills T., Fogo A., Ichikawa I. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from antioxidant injuries. Kidney International 1991; 40: 291–301
   PubMed Web of Science ®Google Scholar
• Macconi D., Zanoli A. F., Orisio S., Longaretti L., Magrini L., Rota S., Radice A., Pozzi C., Remuzzi G. Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitidis. Kidney International 1993; 44: 215–220
   PubMed Web of Science ®Google Scholar
• Yoshioka T., Kawamura T., Meyrick B. O., Beckman J. K., Hoover R. L., Yoshida H., Ichikawa I. Induction of manganese superoxide dismutase by glucocorticoids in glomerular cells. Kidney International 1994; 45: 211–219
   PubMed Web of Science ®Google Scholar
• Newman J. H., Fulkerson W. J., Kobayashi T., English D., Meyrick B., Brigham K. Effects of methylprednisolone on lung oxygen toxicity in awake sheep. Journal of Applied Physiology 1986; 60: 1386–1392
   PubMed Web of Science ®Google Scholar
• Critchley J. A., Beeley J. M., Clark R. J., Summerfield M., Bell S., Spurlock M. S., Edginton J. A., Buchanan J. D. Evaluation of N-acetylcysteine and methylprednisolone as therapies for oxygen and acrolein-induced lung damage. Environmental Health Perspectives 1990; 85: 89–94
   PubMed Web of Science ®Google Scholar